Catherine Berry
Impact in
-
- Allergic Rhinitis and Sensitization
-
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
Papers in
-
- Inflammatory mediators and NSAID effects 7
-
- Viral Infections and Vectors 3
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- J.R.S. Hoult (8 shared papers)Catherine Lunven (4 shared papers)Susan H. Peers (1 shared paper)Valérie Lecouturier (6 shared papers)Stephen E. O'Connor (3 shared papers)Philip K. Moore (3 shared papers)R. Griffiths (3 shared papers)Vincent Pavot (4 shared papers)
- Journals
- British Journal of Pharmacology (5 papers)Biochemical Pharmacology (3 papers)Nature Communications (2 papers)Vaccine (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Catherine Berry
22 papers receiving 240 citations
Peers
Comparison fields: 5 of 60
- Immunology and Allergy 20
- Infectious Diseases 55
- Biochemistry 22
- Pharmacology 46
- Hematology 23
Countries citing papers authored by Catherine Berry
This map shows the geographic impact of Catherine Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Berry more than expected).
Fields of papers citing papers by Catherine Berry
This network shows the impact of papers produced by Catherine Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Berry. The network helps show where Catherine Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 30 | |
| 2 | 2022 | 26 | |
| 3 | 1998 | 21 | |
| 4 | 2003 | 18 | |
| 5 | Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. | 1995 | 18 |
| 6 | 2020 | 14 | |
| 7 | 1986 | 14 | |
| 8 | 1985 | 14 | |
| 9 | 1988 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2000 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 1996 | 9 | |
| 14 | 1992 | 9 | |
| 15 | 1990 | 8 | |
| 16 | 1985 | 6 | |
| 17 | 1984 | 5 | |
| 18 | 2018 | 4 | |
| 19 | Gossypol is a potent inhibitor of the NAD+-dependent dehydrogenase responsible for the inactivation of prostaglandins. | 1985 | 4 |
| 20 | 2023 | 2 |
About Catherine Berry
Catherine Berry is a scholar working on Pharmacology, Infectious Diseases, Hematology, Biochemistry and Molecular Biology, having authored 22 papers that have together received 252 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Viral Infections and Vectors (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mosquito-borne diseases and control (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Helicobacter pylori-related gastroenterology studies (2 papers). The work is most often cited by research in Immunology and Allergy (20 citations), Infectious Diseases (55 citations), Biochemistry (22 citations), Pharmacology (46 citations) and Hematology (23 citations). Catherine Berry has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include J.R.S. Hoult, Catherine Lunven, Susan H. Peers, Valérie Lecouturier, Stephen E. O'Connor, Philip K. Moore, R. Griffiths, Vincent Pavot, B. Scatton and Kenneth G. Lloyd. Their work appears in journals such as British Journal of Pharmacology, Biochemical Pharmacology, Nature Communications, Vaccine and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.